StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
15
This year
2
Publishing Date
2024 - 03 - 13
1
2024 - 02 - 12
1
2023 - 11 - 02
1
2023 - 05 - 08
1
2023 - 03 - 14
1
2023 - 02 - 07
1
2022 - 11 - 01
1
2022 - 08 - 02
1
2022 - 05 - 26
1
2022 - 05 - 05
1
2022 - 05 - 03
1
2022 - 03 - 25
1
2022 - 03 - 23
1
2021 - 11 - 04
1
2021 - 11 - 02
1
Sector
Health technology
15
Manufacturing
1
Tags
Approval
1
Biocapital
3
Cancer
2
Car-t
1
Chmp
1
Companies
1
Disease
2
Earnings
6
Ema
1
Events
1
Expansion
1
Financial
3
Financial results
1
Global
1
Growth
1
Jakavi
2
Market
2
Meeting
2
N/a
4
Pancreatic
1
Platform
1
Positive
1
Presentation
1
Regulatory
1
Report
2
Results
5
Treatment
2
Update
1
Year
1
Entities
3m company
8
Abbott laboratories
106
Abbvie inc.
218
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
12
Alcon inc.
14
Alkermes plc
7
Amgen inc.
168
Astellas pharma inc
70
Astrazeneca plc
172
Autolus therapeutics plc
7
Bausch health companies inc.
61
Baxter international inc.
45
Becton, dickinson and company
17
Beigene, ltd.
7
Biogen inc.
47
Biomarin pharmaceutical inc.
6
Biontech se
9
Boston scientific corporation
13
Brainstorm cell therapeutics inc.
8
Bristol-myers squibb company
82
Chinook therapeutics, inc.
7
Csl ltd
9
Danaher corporation
10
Eli lilly and company
121
Endo international plc
20
General electric company
8
Genmab a/s
12
Gilead sciences, inc.
25
Glaxosmithkline plc
265
Grifols sa
10
Incyte corporation
15
Ionis pharmaceuticals, inc.
7
Jazz pharmaceuticals plc
13
Johnson & johnson
189
Koninklijke philips n.v.
17
Mallinckrodt plc
17
Medtronic plc
29
Morphosys ag
13
Novartis ag
1035
Novo nordisk a/s
27
Orange
8
Orchard therapeutics plc
8
Perrigo company
7
Pfizer, inc.
68
Precision biosciences, inc.
8
Reckitt benckiser group plc
10
Regeneron pharmaceuticals, inc.
12
Regenxbio inc.
11
Sanofi
285
Smith & nephew plc
7
Stryker corporation
10
Takeda pharmaceutical company limited
51
Terumo corp
9
Teva pharmaceutical industries limited
9
Teva pharmaceutical industries ltd
206
Thermo fisher scientific inc
48
Ucb s.a.
8
Viatris inc.
115
Xencor, inc.
9
Symbols
ABBV
17
ACAD
4
ADCT
13
AGEN
3
AGIO
11
ALKS
5
ALNY
14
ALPMF
6
ALPMY
6
ALPN
3
AMGN
12
AVEO
18
BCTX
4
BGNE
12
BIIB
4
BMY
24
BNTX
6
BPMC
23
CLVS
19
EPZM
21
EXEL
14
GBT
5
GLAXF
7
GSK
7
ILMN
10
INCY
445
IONS
7
IOVA
5
IRWD
4
JAZZ
5
JNJ
22
KPTI
18
LLY
207
LPTX
4
MGNX
11
MOR
28
MPSYF
19
MRUS
14
NBIX
4
NVS
21
NVSEF
15
PFE
14
PTCT
4
RARE
6
RCUS
4
REGN
18
RIGL
10
SAGE
4
SGEN
4
SNDX
5
SNY
121
SNYNF
102
SRPT
4
SYRS
11
TAK
16
URGN
4
UTHR
4
VSTM
10
XNCR
37
YMAB
18
Exchanges
Amex
1
Nasdaq
15
Nyse
15
Crawled Date
2024 - 03 - 13
1
2024 - 02 - 12
1
2023 - 11 - 02
1
2023 - 05 - 08
1
2023 - 03 - 15
1
2023 - 02 - 07
1
2022 - 11 - 01
1
2022 - 08 - 02
1
2022 - 05 - 26
1
2022 - 05 - 05
1
2022 - 05 - 03
1
2022 - 03 - 25
1
2022 - 03 - 23
1
2021 - 11 - 04
1
2021 - 11 - 02
1
Crawled Time
01:00
1
10:00
1
11:00
2
12:00
4
13:00
1
14:00
1
15:00
1
15:15
1
18:00
1
23:00
2
Source
www.biospace.com
11
www.globenewswire.com
1
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Incyte corporation
symbols :
Nvsef
save search
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published:
2024-03-13
(Crawled : 23:00)
- biospace.com/
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
-2.36%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
-0.91%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
XNCR
|
$18.37
0.88%
0.76%
480K
|
Health Technology
|
-19.43%
|
O:
-0.66%
H:
4.19%
C:
3.13%
MOR
|
News
|
$18.04
0.45%
0.44%
180K
|
Health Technology
|
-0.72%
|
O:
0.22%
H:
0.22%
C:
-0.93%
INCY
|
$51.65
-0.52%
-0.58%
11
|
Health Technology
|
-12.94%
|
O:
0.03%
H:
1.47%
C:
-0.72%
year
update
financial
results
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
0
|
Health Technology
|
-4.81%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
16.27%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
News
|
$9.49
-0.42%
-1.11%
55K
|
Manufacturing
|
-12.29%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.38
0.15%
1.94%
1.7M
|
Health Technology
|
-6.74%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
-1.66%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$149.56
0.3%
0.03%
140K
|
Health Technology
|
-4.43%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
1.6K
|
Health Technology
|
0.41%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$745.69
1.96%
0.04%
4K
|
Health Technology
|
0.24%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.99
-0.31%
0.41%
7.1M
|
Health Technology
|
-1.53%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
-2.04%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$15.12
0.87%
0.93%
430K
|
Health Technology
|
-16.97%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
$404.91
1.25%
1.43%
730K
|
Health Technology
|
-3.25%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$47.69
1.15%
1.13%
1.6M
|
Health Technology
|
1.86%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.37
-2.27%
-7.02%
2
|
Health Technology
|
-8.14%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$51.65
-0.52%
-0.58%
11
|
Health Technology
|
-10.7%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$193.18
-0.48%
5.8%
1.2M
|
Health Technology
|
-21.07%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
15.37%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$375.08
1.72%
1.7%
1.3K
|
Health Technology
|
-4.49%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
News
|
$273.54
0.6%
0.65%
8.5K
|
Health Technology
|
-7.1%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Incyte to Spotlight More Than 40 Hematology and Oncology Abstracts Including a Plenary Presentation at the ASH Annual Meeting
Published:
2023-11-02
(Crawled : 18:00)
- biospace.com/
TAK
|
News
|
$13.38
0.15%
1.94%
1.7M
|
Health Technology
|
-2.23%
|
O:
1.03%
H:
0.73%
C:
0.58%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
4.88%
|
O:
-1.09%
H:
1.03%
C:
0.91%
XNCR
|
$18.37
0.88%
0.76%
480K
|
Health Technology
|
5.15%
|
O:
1.32%
H:
0.45%
C:
-1.19%
MOR
|
News
|
$18.04
0.45%
0.44%
180K
|
Health Technology
|
122.17%
|
O:
2.22%
H:
0.6%
C:
-9.4%
INCY
|
$51.65
-0.52%
-0.58%
11
|
Health Technology
|
-5.0%
|
O:
-0.28%
H:
1.0%
C:
-0.46%
presentation
meeting
Global Pancreatic Cancer Competitive Landscape Report 2023: Comprehensive Insights about 250+ Companies and 300+ Drugs
Published:
2023-05-08
(Crawled : 15:00)
- prnewswire.com
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
-5.6%
|
O:
-0.11%
H:
0.72%
C:
0.3%
TCRR
4
|
$1.48
3.38%
3.9M
|
Health Technology
|
-21.28%
|
O:
6.91%
H:
1.49%
C:
-2.49%
INCY
|
$51.65
-0.52%
-0.58%
11
|
Health Technology
|
-22.4%
|
O:
0.03%
H:
0.17%
C:
-1.19%
BNTX
|
News
|
$88.49
0.55%
0.59%
1K
|
Health Technology
|
-18.39%
|
O:
4.23%
H:
0.0%
C:
-4.4%
ADAP
|
$1.14
12.87%
9.82%
1.1M
|
Health Technology
|
-18.57%
|
O:
1.43%
H:
2.11%
C:
-1.41%
companies
report
cancer
pancreatic
global
Incyte Announces Data from Across its Oncology Portfolio will be Presented at the AACR Annual Meeting 2023
Published:
2023-03-14
(Crawled : 01:00)
- biospace.com/
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
40.92%
|
O:
-0.18%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
21.14%
|
O:
0.28%
H:
0.38%
C:
0.31%
XNCR
|
$18.37
0.88%
0.76%
480K
|
Health Technology
|
-35.34%
|
O:
1.2%
H:
0.17%
C:
-1.67%
MOR
|
News
|
$18.04
0.45%
0.44%
180K
|
Health Technology
|
361.38%
|
O:
-1.79%
H:
3.39%
C:
3.39%
INCY
|
$51.65
-0.52%
-0.58%
11
|
Health Technology
|
-29.42%
|
O:
0.18%
H:
1.06%
C:
0.94%
meeting
Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical Programs
Published:
2023-02-07
(Crawled : 13:00)
- biospace.com/
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
39.25%
|
O:
2.27%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.38
0.15%
1.94%
1.7M
|
Health Technology
|
-15.54%
|
O:
-0.13%
H:
1.01%
C:
0.89%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
15.67%
|
O:
0.29%
H:
0.86%
C:
0.72%
XNCR
|
$18.37
0.88%
0.76%
480K
|
Health Technology
|
-49.84%
|
O:
-0.19%
H:
1.15%
C:
-2.27%
MOR
|
News
|
$18.04
0.45%
0.44%
180K
|
Health Technology
|
260.08%
|
O:
1.6%
H:
0.0%
C:
-0.59%
INCY
|
$51.65
-0.52%
-0.58%
11
|
Health Technology
|
-38.77%
|
O:
-1.02%
H:
0.29%
C:
-3.04%
financial
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published:
2022-11-01
(Crawled : 12:00)
- biospace.com/
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
47.11%
|
O:
1.13%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.38
0.15%
1.94%
1.7M
|
Health Technology
|
0.95%
|
O:
0.68%
H:
1.05%
C:
-0.23%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
21.85%
|
O:
0.47%
H:
0.09%
C:
-0.55%
XNCR
|
$18.37
0.88%
0.76%
480K
|
Health Technology
|
-34.39%
|
O:
1.07%
H:
2.51%
C:
-0.11%
MOR
|
News
|
$18.04
0.45%
0.44%
180K
|
Health Technology
|
272.73%
|
O:
3.1%
H:
1.8%
C:
-0.6%
INCY
|
$51.65
-0.52%
-0.58%
11
|
Health Technology
|
-30.52%
|
O:
1.59%
H:
7.26%
C:
1.89%
financial
results
Incyte Reports 2022 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published:
2022-08-02
(Crawled : 12:00)
- biospace.com/
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
28.36%
|
O:
-2.62%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.38
0.15%
1.94%
1.7M
|
Health Technology
|
-6.81%
|
O:
-1.33%
H:
0.78%
C:
-1.06%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
15.45%
|
O:
-0.02%
H:
0.39%
C:
-0.64%
XNCR
|
$18.37
0.88%
0.76%
480K
|
Health Technology
|
-34.42%
|
O:
-0.32%
H:
5.09%
C:
3.9%
MOR
|
News
|
$18.04
0.45%
0.44%
180K
|
Health Technology
|
219.86%
|
O:
-3.37%
H:
3.3%
C:
0.92%
INCY
|
$51.65
-0.52%
-0.58%
11
|
Health Technology
|
-33.27%
|
O:
-4.39%
H:
0.2%
C:
-1.92%
results
Data from Incyte’s Robust and Progressing Oncology Portfolio to be Presented at 2022 EHA Annual Meeting
Published:
2022-05-26
(Crawled : 11:00)
- biospace.com/
TAK
|
News
|
$13.38
0.15%
1.94%
1.7M
|
Health Technology
|
-10.59%
|
O:
-0.17%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
8.19%
|
O:
-0.11%
H:
0.0%
C:
0.0%
XNCR
|
$18.37
0.88%
0.76%
480K
|
Health Technology
|
-18.82%
|
O:
-0.33%
H:
0.0%
C:
0.0%
MOR
|
News
|
$18.04
0.45%
0.44%
180K
|
Health Technology
|
250.29%
|
O:
3.5%
H:
2.14%
C:
0.19%
INCY
|
$51.65
-0.52%
-0.58%
11
|
Health Technology
|
-31.98%
|
O:
1.26%
H:
0.95%
C:
-1.13%
Incyte Announces European Commission Approval of Jakavi® (ruxolitinib) as the First Post-Steroid Treatment for Acute and Chronic Graft-Versus-Host Disease
Published:
2022-05-05
(Crawled : 10:00)
- biospace.com/
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
13.01%
|
O:
-0.39%
H:
0.15%
C:
-1.07%
INCY
|
$51.65
-0.52%
-0.58%
11
|
Health Technology
|
-33.43%
|
O:
3.73%
H:
0.09%
C:
-3.98%
jakavi
treatment
disease
approval
Incyte Reports 2022 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Published:
2022-05-03
(Crawled : 12:00)
- biospace.com/
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
12.97%
|
O:
0.06%
H:
0.0%
C:
0.0%
XNCR
|
$18.37
0.88%
0.76%
480K
|
Health Technology
|
-27.85%
|
O:
2.08%
H:
1.96%
C:
-0.77%
MOR
|
News
|
$18.04
0.45%
0.44%
180K
|
Health Technology
|
240.38%
|
O:
2.45%
H:
0.92%
C:
-2.03%
INCY
|
$51.65
-0.52%
-0.58%
11
|
Health Technology
|
-30.71%
|
O:
2.12%
H:
4.06%
C:
1.39%
results
Incyte Announces Positive CHMP Opinion for Ruxolitinib (Jakavi®) for the Treatment of Acute and Chronic Graft-Versus-Host Disease
Published:
2022-03-25
(Crawled : 14:00)
- biospace.com/
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
15.01%
|
O:
1.14%
H:
0.0%
C:
0.0%
INCY
|
$51.65
-0.52%
-0.58%
11
|
Health Technology
|
-33.94%
|
O:
0.33%
H:
0.29%
C:
0.01%
jakavi
treatment
disease
positive
chmp
Head and Neck Cancer Market worth $ 9.07 Billion by 2030 - Exclusive Report by InsightAce Analytic
Published:
2022-03-23
(Crawled : 11:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
0
|
Health Technology
|
-5.05%
|
O:
3.81%
H:
0.0%
C:
-0.44%
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
9.68%
|
O:
-4.55%
H:
6.28%
C:
6.28%
PFE
|
News
4
|
$26.32
0.23%
0.15%
20M
|
Health Technology
|
-51.4%
|
O:
-1.94%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
15.13%
|
O:
-0.6%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
1.6K
|
Health Technology
|
-5.09%
|
O:
-0.87%
H:
0.0%
C:
0.0%
BMY
|
$48.99
-0.31%
0.41%
7.1M
|
Health Technology
|
-31.17%
|
O:
-0.55%
H:
0.0%
C:
0.0%
MGNX
|
$16.23
5.32%
5.05%
650K
|
Health Technology
|
77.57%
|
O:
-1.31%
H:
3.88%
C:
-0.67%
KURA
|
News
|
$18.73
2.97%
2.93%
1
|
Health Technology
|
14.28%
|
O:
-1.34%
H:
0.12%
C:
-2.6%
INCY
|
$51.65
-0.52%
-0.58%
11
|
Health Technology
|
-33.82%
|
O:
0.04%
H:
0.08%
C:
-1.26%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
11.5%
|
O:
-0.31%
H:
1.85%
C:
1.55%
ADXS
|
$0.54
-5.59%
12.48%
0
|
Health Technology
|
342.62%
|
O:
-1.64%
H:
8.33%
C:
0.0%
CVM
|
$1.47
-2.65%
2.72%
180K
|
Health Technology
|
-66.28%
|
O:
-0.92%
H:
2.31%
C:
-3.47%
report
cancer
market
New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio
Published:
2021-11-04
(Crawled : 15:15)
- globenewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
14.63%
|
O:
0.18%
H:
0.0%
C:
-0.89%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
18.27%
|
O:
-0.06%
H:
0.28%
C:
0.18%
INCY
|
$51.65
-0.52%
-0.58%
11
|
Health Technology
|
-20.05%
|
O:
2.41%
H:
0.0%
C:
0.0%
ema
car-t
platform
Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published:
2021-11-02
(Crawled : 12:00)
- biospace.com/
TAK
|
News
|
$13.38
0.15%
1.94%
1.7M
|
Health Technology
|
-5.69%
|
O:
0.49%
H:
0.56%
C:
-0.07%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
17.92%
|
O:
0.3%
H:
0.15%
C:
-0.4%
XNCR
|
$18.37
0.88%
0.76%
480K
|
Health Technology
|
-53.93%
|
O:
2.7%
H:
1.01%
C:
0.85%
MOR
|
News
|
$18.04
0.45%
0.44%
180K
|
Health Technology
|
52.17%
|
O:
3.75%
H:
1.22%
C:
1.22%
INCY
|
$51.65
-0.52%
-0.58%
11
|
Health Technology
|
-22.71%
|
O:
-1.93%
H:
0.19%
C:
-3.14%
financial results
results
Gainers vs Losers
76%
24%
Top 10 Gainers
AGBA
|
$2.97
137.6%
54.87%
66M
|
Finance
HKIT
|
$1.33
30.39%
27.14%
39K
|
Technology Services
VRT
4
|
$79.17
4.08%
19.36%
6.6M
|
Electronic Technology
FOA
4
|
$0.5144
-8.16%
15.43%
20
|
Finance and Insurance
EAST
|
$1.0835
16.17%
15.21%
100
|
Commercial Services
BOF
|
$1.17
6.36%
14.73%
15K
|
LUCY
|
$0.2545
9.93%
13.94%
66K
|
n/a
MARA
|
$19.44
10.77%
10.28%
630K
|
Commercial Services
TSLA
|
News
|
$144.68
1.85%
9.01%
93M
|
Consumer Durables
BNED
|
$0.2064
2.64%
8.96%
1.4M
|
Retail Trade
Your saved searches
Save your searches and get alerts when important news are released.